Age-related macular degeneration (AMD) is a frequent cause of blindness influenced by environmental and genetic risk factors. While current knowledge on AMD genetics and its use in diagnostic testing is readily present in press and electronic media, risk quantification is still a challenge when communicating testing results. Here we ask whether and how this information is perceived by the public, specifically in light of the lack of preventive and therapeutic measures of this devastating disease.
|Translated title of the contribution||Genetic risk in age-related macular degeneration|
|Number of pages||3|
|Publication status||Published - 12 Nov 2015|